PELVIC FLOOR MUSCLE EXERCISE AND PHYSICAL THERAPY MAY IMPROVE SYSTEMIC SCLEROSIS-ASSOCIATED FECAL INCONTINENCE

Keywords: Fecal incontinence, Exercise therapy, Systemic sclerosis, Physical therapy

Abstract

Gastrointestinal involvement in systemic sclerosis (SSc) is observed in up to 90% of patients. Resolution of some of these gastrointestinal complications is challenging without the support of physical therapy and rehabilitation. One of these complications, SSc-associated fecal incontinence, which can be devastating for those affected, is seen in up to 39%. Studies focusing on fecal incontinence and its treatment are scarce. The hypothesis presented herein suggests that pelvic floor muscle exercise, biofeedback therapy, and neuromodulation methods might be effective and safe treatment strategies for patients affected by this debilitating complication.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Flachenecker P. Autoimmune diseases and rehabilitation. Autoimmun Rev 2012;11(3):219-225.

Akinci A, Kiliç G. Future of rehabilitation interventions for rheumatic patients in the Mediterranean Region. Mediterr J Rheumatol 2017;28(2):70-74.

Orlandi M, Lepri G, Damiani A, Barsotti S, Di Battista M, Codullo V, et al. One year in review 2020: systemic sclerosis. Clin Exp Rheumatol 2020;125(3):3-17.

Liem SIE, Vliet Vlieland TPM, Schoones JW, de Vries-Bouwstra JK. The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review. Rheumatol Adv Pract 2019;3(2):rkz044.

Kröner PT, Tolaymat OA, Bowman AW, Abril A, Lacy BE. Gastrointestinal manifestations of rheumatological diseases. Am J Gastroenterol 2019;114(9):1441-1454.

Yang H, Xu D, Li MT, Yao Y, Jin M, Zeng XF, et al. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis. J Dig Dis 2019;20(5):256-261.

Richard N, Hudson M, Gyger G, Baron M, Sutton E, Khalidi N, et al. Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues. Rheumatology (Oxford) 2017;56(4):581-588.

Collins J, Mazor Y, Jones M, Kellow J, Malcolm A. Efficacy of anorectal biofeedback in scleroderma patients with fecal incontinence: a case-control study. Scand J Gastroenterol 2016;51(12):1433-1438.

Emmanuel A. Current management of the gastrointestinal complications of systemic sclerosis. Nat Rev Gastroenterol Hepatol 2016;13(8):461-472.

Kenefick NJ, Vaizey CJ, Nicholls RJ, Cohen R, Kamm MA. Sacral nerve stimulation for faecal incontinence due to systemic sclerosis. Gut 2002;51(6):881-883.

Fernández-Codina A, Walker KM, Pope JE. Scleroderma algorithm group. Treatment algorithms for systemic sclerosis according to experts. Arthritis Rheumatol 2018;70(11):1820-1828.

Khanna D, Furst DE, Allanore Y, Bae S, Bodukam V, Clements PJ, et al. Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards. Rheumatology (Oxford) 2015;54(1):144-151.

Furst DE, Braun-Moscovic Y, Khanna D. Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis. Rheumatology (Oxford) 2017;56(suppl_5):v4-v11.

Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. Scientific hypotheses: writing, promoting, and predicting implications. J Korean Med Sci 2019;34(45):e300.

Benlidayi IC. Statistical accuracy in rheumatology research. Mediterr J Rheumatol 2020;30(4):207-215.

Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010;7:e1000251.

Published
2021-07-03